Biopharmaceutical supply chains: distribution, regulatory, systems and structural changes ahead
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boca Raton
CRC Press
[2010]
|
| Schlagworte: | |
| Online-Zugang: | TUM01 Volltext |
| Beschreibung: | Includes bibliographical references |
| Beschreibung: | 1 Online-Ressource (ix, 241 Seiten) |
| ISBN: | 1439899703 1439899797 9781439899700 9781439899793 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042741702 | ||
| 003 | DE-604 | ||
| 005 | 20151118 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150806s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 1439899703 |9 1-4398-9970-3 | ||
| 020 | |a 1439899797 |9 1-4398-9979-7 | ||
| 020 | |a 9781439899700 |9 978-1-4398-9970-0 | ||
| 020 | |a 9781439899793 |c Online |9 978-1-4398-9979-3 | ||
| 035 | |a (OCoLC)795120447 | ||
| 035 | |a (DE-599)BVBBV042741702 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 082 | 0 | |a 338.4/79151 |2 23 | |
| 100 | 1 | |a Handfield, Robert B. |d 1964- |e Verfasser |0 (DE-588)1071826794 |4 aut | |
| 245 | 1 | 0 | |a Biopharmaceutical supply chains |b distribution, regulatory, systems and structural changes ahead |c Robert Handfield |
| 264 | 1 | |a Boca Raton |b CRC Press |c [2010] | |
| 264 | 4 | |c © 2012 | |
| 300 | |a 1 Online-Ressource (ix, 241 Seiten) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references | ||
| 505 | 8 | |a 1. Biopharmaceutical Distribution: Early Structural Developments and the Changes Ahead -- 2. Key Forces and Myths of Distribution in the BPS Supply Chain -- 3. Regulatory Trends -- 4. The Last Mile: Changes in the Hospital Environment That Impact the Life Sciences -- 5. The Blurring of Boundaries in Biopharmaceutical Supply Chains: The Case of Oncology Medicine -- 6. The Changing Landscape of the Life Sciences Supply Chain: Recommendations for Players in the Industry | |
| 505 | 8 | |a "The global pharmaceutical industry has been subjected to many challenges in the last decade, including more blockbuster drugs reaching the end of their patent life, increased regulation, pricing pressure, channel pressure, counterfeiting, and challenges in clinical trials management. This book covers the major themes and changes in the biopharmaceutical supply chain. It provides an overview of the key challenges and discusses how leading biopharma companies are dealing with these challenges. Bringing together leading researchers and industry executives, it is a must-read for those who want to learn more about achieving success in this industry"--Provided by publisher | |
| 650 | 7 | |a BUSINESS & ECONOMICS / Industries / General |2 bisacsh | |
| 650 | 4 | |a Industrie | |
| 650 | 4 | |a Wirtschaft | |
| 650 | 4 | |a Pharmaceutical industry |x Materials management | |
| 650 | 4 | |a Business logistics | |
| 650 | 0 | 7 | |a Biologika |0 (DE-588)7689632-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Supply Chain Management |0 (DE-588)4684051-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Biologika |0 (DE-588)7689632-8 |D s |
| 689 | 0 | 1 | |a Supply Chain Management |0 (DE-588)4684051-5 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=459428 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028172572 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=459428 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCOBAE_gekauft |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804174955718377472 |
|---|---|
| any_adam_object | |
| author | Handfield, Robert B. 1964- |
| author_GND | (DE-588)1071826794 |
| author_facet | Handfield, Robert B. 1964- |
| author_role | aut |
| author_sort | Handfield, Robert B. 1964- |
| author_variant | r b h rb rbh |
| building | Verbundindex |
| bvnumber | BV042741702 |
| collection | ZDB-4-NLEBK |
| contents | 1. Biopharmaceutical Distribution: Early Structural Developments and the Changes Ahead -- 2. Key Forces and Myths of Distribution in the BPS Supply Chain -- 3. Regulatory Trends -- 4. The Last Mile: Changes in the Hospital Environment That Impact the Life Sciences -- 5. The Blurring of Boundaries in Biopharmaceutical Supply Chains: The Case of Oncology Medicine -- 6. The Changing Landscape of the Life Sciences Supply Chain: Recommendations for Players in the Industry "The global pharmaceutical industry has been subjected to many challenges in the last decade, including more blockbuster drugs reaching the end of their patent life, increased regulation, pricing pressure, channel pressure, counterfeiting, and challenges in clinical trials management. This book covers the major themes and changes in the biopharmaceutical supply chain. It provides an overview of the key challenges and discusses how leading biopharma companies are dealing with these challenges. Bringing together leading researchers and industry executives, it is a must-read for those who want to learn more about achieving success in this industry"--Provided by publisher |
| ctrlnum | (OCoLC)795120447 (DE-599)BVBBV042741702 |
| dewey-full | 338.4/79151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/79151 |
| dewey-search | 338.4/79151 |
| dewey-sort | 3338.4 579151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03163nmm a2200517zc 4500</leader><controlfield tag="001">BV042741702</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20151118 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150806s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1439899703</subfield><subfield code="9">1-4398-9970-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1439899797</subfield><subfield code="9">1-4398-9979-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781439899700</subfield><subfield code="9">978-1-4398-9970-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781439899793</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4398-9979-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)795120447</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042741702</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/79151</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Handfield, Robert B.</subfield><subfield code="d">1964-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1071826794</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biopharmaceutical supply chains</subfield><subfield code="b">distribution, regulatory, systems and structural changes ahead</subfield><subfield code="c">Robert Handfield</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton</subfield><subfield code="b">CRC Press</subfield><subfield code="c">[2010]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (ix, 241 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">1. Biopharmaceutical Distribution: Early Structural Developments and the Changes Ahead -- 2. Key Forces and Myths of Distribution in the BPS Supply Chain -- 3. Regulatory Trends -- 4. The Last Mile: Changes in the Hospital Environment That Impact the Life Sciences -- 5. The Blurring of Boundaries in Biopharmaceutical Supply Chains: The Case of Oncology Medicine -- 6. The Changing Landscape of the Life Sciences Supply Chain: Recommendations for Players in the Industry</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">"The global pharmaceutical industry has been subjected to many challenges in the last decade, including more blockbuster drugs reaching the end of their patent life, increased regulation, pricing pressure, channel pressure, counterfeiting, and challenges in clinical trials management. This book covers the major themes and changes in the biopharmaceutical supply chain. It provides an overview of the key challenges and discusses how leading biopharma companies are dealing with these challenges. Bringing together leading researchers and industry executives, it is a must-read for those who want to learn more about achieving success in this industry"--Provided by publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Industries / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Materials management</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Business logistics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biologika</subfield><subfield code="0">(DE-588)7689632-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Supply Chain Management</subfield><subfield code="0">(DE-588)4684051-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Biologika</subfield><subfield code="0">(DE-588)7689632-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Supply Chain Management</subfield><subfield code="0">(DE-588)4684051-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=459428</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028172572</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=459428</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCOBAE_gekauft</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV042741702 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:08:37Z |
| institution | BVB |
| isbn | 1439899703 1439899797 9781439899700 9781439899793 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028172572 |
| oclc_num | 795120447 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (ix, 241 Seiten) |
| psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCOBAE_gekauft |
| publishDate | 2010 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | CRC Press |
| record_format | marc |
| spelling | Handfield, Robert B. 1964- Verfasser (DE-588)1071826794 aut Biopharmaceutical supply chains distribution, regulatory, systems and structural changes ahead Robert Handfield Boca Raton CRC Press [2010] © 2012 1 Online-Ressource (ix, 241 Seiten) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references 1. Biopharmaceutical Distribution: Early Structural Developments and the Changes Ahead -- 2. Key Forces and Myths of Distribution in the BPS Supply Chain -- 3. Regulatory Trends -- 4. The Last Mile: Changes in the Hospital Environment That Impact the Life Sciences -- 5. The Blurring of Boundaries in Biopharmaceutical Supply Chains: The Case of Oncology Medicine -- 6. The Changing Landscape of the Life Sciences Supply Chain: Recommendations for Players in the Industry "The global pharmaceutical industry has been subjected to many challenges in the last decade, including more blockbuster drugs reaching the end of their patent life, increased regulation, pricing pressure, channel pressure, counterfeiting, and challenges in clinical trials management. This book covers the major themes and changes in the biopharmaceutical supply chain. It provides an overview of the key challenges and discusses how leading biopharma companies are dealing with these challenges. Bringing together leading researchers and industry executives, it is a must-read for those who want to learn more about achieving success in this industry"--Provided by publisher BUSINESS & ECONOMICS / Industries / General bisacsh Industrie Wirtschaft Pharmaceutical industry Materials management Business logistics Biologika (DE-588)7689632-8 gnd rswk-swf Supply Chain Management (DE-588)4684051-5 gnd rswk-swf Biologika (DE-588)7689632-8 s Supply Chain Management (DE-588)4684051-5 s 1\p DE-604 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=459428 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Handfield, Robert B. 1964- Biopharmaceutical supply chains distribution, regulatory, systems and structural changes ahead 1. Biopharmaceutical Distribution: Early Structural Developments and the Changes Ahead -- 2. Key Forces and Myths of Distribution in the BPS Supply Chain -- 3. Regulatory Trends -- 4. The Last Mile: Changes in the Hospital Environment That Impact the Life Sciences -- 5. The Blurring of Boundaries in Biopharmaceutical Supply Chains: The Case of Oncology Medicine -- 6. The Changing Landscape of the Life Sciences Supply Chain: Recommendations for Players in the Industry "The global pharmaceutical industry has been subjected to many challenges in the last decade, including more blockbuster drugs reaching the end of their patent life, increased regulation, pricing pressure, channel pressure, counterfeiting, and challenges in clinical trials management. This book covers the major themes and changes in the biopharmaceutical supply chain. It provides an overview of the key challenges and discusses how leading biopharma companies are dealing with these challenges. Bringing together leading researchers and industry executives, it is a must-read for those who want to learn more about achieving success in this industry"--Provided by publisher BUSINESS & ECONOMICS / Industries / General bisacsh Industrie Wirtschaft Pharmaceutical industry Materials management Business logistics Biologika (DE-588)7689632-8 gnd Supply Chain Management (DE-588)4684051-5 gnd |
| subject_GND | (DE-588)7689632-8 (DE-588)4684051-5 |
| title | Biopharmaceutical supply chains distribution, regulatory, systems and structural changes ahead |
| title_auth | Biopharmaceutical supply chains distribution, regulatory, systems and structural changes ahead |
| title_exact_search | Biopharmaceutical supply chains distribution, regulatory, systems and structural changes ahead |
| title_full | Biopharmaceutical supply chains distribution, regulatory, systems and structural changes ahead Robert Handfield |
| title_fullStr | Biopharmaceutical supply chains distribution, regulatory, systems and structural changes ahead Robert Handfield |
| title_full_unstemmed | Biopharmaceutical supply chains distribution, regulatory, systems and structural changes ahead Robert Handfield |
| title_short | Biopharmaceutical supply chains |
| title_sort | biopharmaceutical supply chains distribution regulatory systems and structural changes ahead |
| title_sub | distribution, regulatory, systems and structural changes ahead |
| topic | BUSINESS & ECONOMICS / Industries / General bisacsh Industrie Wirtschaft Pharmaceutical industry Materials management Business logistics Biologika (DE-588)7689632-8 gnd Supply Chain Management (DE-588)4684051-5 gnd |
| topic_facet | BUSINESS & ECONOMICS / Industries / General Industrie Wirtschaft Pharmaceutical industry Materials management Business logistics Biologika Supply Chain Management |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=459428 |
| work_keys_str_mv | AT handfieldrobertb biopharmaceuticalsupplychainsdistributionregulatorysystemsandstructuralchangesahead |